Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1

Conditions

Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Thyroid Nodule 1Pneumothorax 1Pleural Neoplasms 1Parathyroid Neoplasms 1Nasopharyngeal Carcinoma 1Mesothelioma 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Diarrhea 1Colonic Neoplasms 1

Interventions

pembrolizumab 12Nivolumab 4tislelizumab 2spartalizumab 2belinostat 2atezolizumab 2Ipilimumab 2venetoclax 1tocilizumab 1talazoparib 1rovalpituzumab tesirine 1obinutuzumab 1naptumomab estafenatox 1milademetan 1epacadostat 1durvalumab 1budigalimab 1Tablets 1Sorafenib 1Sirolimus 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1LY2940680 1Immunotherapy 1Fluorouracil 1Drug Therapy 1Doxepin 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Control Groups × Head & Neck × Clear all
NCT01776385 2018-07-23

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Centre Hospitalier Universitaire de Nice

Phase NA Completed
9 enrolled
Head & NeckOther solid neoplasmThoracic

Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Pneumothorax, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡